RRx-001, an epigenetic-based radio- and chemosensitizer, has vascular normalizing effects on SCCVII and U87 tumors

Beyond Antiangiogenesis: Vascular Modulation as an Anticancer Therapy—A Review

(2014) Bryan T. Oronsky et al.   Translational Oncology

The tumor microenvironment at a glance

(2013) F. R. Balkwill et al.   JOURNAL OF CELL SCIENCE

Dinitroazetidines Are a Novel Class of Anticancer Agents and Hypoxia-Activated Radiation Sensitizers Developed from Highly Energetic Materials

(2012) S. Ning et al.   CANCER RESEARCH

Development of a Safe and Efficient Two-Step Synthesis for Preparing 1-Bromoacetyl-3,3-dinitroazetidine, a Novel Clinical Anticancer Candidate

(2012) Nicholas A. Straessler et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT

Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination

(2010) Einar K. Rofstad et al.   INTERNATIONAL JOURNAL OF CANCER

Provascular strategy: Targeting functional adaptations of mature blood vessels in tumors to selectively influence the tumor vascular reactivity and improve cancer treatment

(2008) Pierre Sonveaux   RADIOTHERAPY AND ONCOLOGY